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Abstract
Mobile elements such as Alu repeats have substantially altered the architecture of the human genome, and de novo mobile element insertions
sometimes cause genetic disorders. Previous estimates for the retrotransposition rate (RR) of Alu elements in humans of one new insertion every
∼100–125births were developed prior to the sequencing of the human and chimpanzee genomes. Here, we used two independent methods (based
on the new genomic data and on disease-causing de novo Alu insertions) to generate refined Alu RR estimates in humans. Both methods
consistently yielded RR on the order of one new Alu insertion every ∼20 births, despite the fact that the evolutionary-based method represents an
average RR over the past ∼6 million years while the mutation-based method better reflects the current-day RR. These results suggest that Alu
elements retrotranspose at a faster rate in humans than previously thought, and support the potential of Alu elements as mutagenic factors in the
human genome.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
About 30% of the human genome is comprised of Alu and
LINE-1 (L1) retrotransposons (Lander et al., 2001), which are
the two major families of mobile elements that are currently
expanding in humans (Smit, 1999; Ostertag and Kazazian,
2001; Batzer and Deininger, 2002; Deininger et al., 2003;
Cordaux et al., 2004; Hedges and Batzer, 2005). New Alu and
L1 copies are generated via a “copy and paste” mechanism, in
which the RNA transcript of an active element is reverse transcribed as cDNA and the duplicate element is inserted at a new
genomic location (Rogers, 1985; Ostertag and Kazazian, 2001;
Batzer and Deininger, 2002). While L1 elements are autonomous because they encode the proteins required for retrotransposition, Alu elements are non-autonomous and are transmobilized by the L1 retrotransposition machinery (Sakaki et al.,
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1986; Skowronski et al., 1988; Feng et al., 1996; Ostertag and
Kazazian, 2001; Wei et al., 2001; Dewannieux et al., 2003).
Alu and L1 elements have substantially impacted the architecture of the genome and their insertions have caused a number of
human genetic disorders (Deininger and Batzer, 1999; Ostertag and
Kazazian, 2001; Batzer and Deininger, 2002; Deininger et al.,
2003; Chen et al., 2005). Because of these extensive interactions, it
is important to understand the dynamics of expansion of these
mobile element families. For instance, how often are new
retrotransposon copies generated in the human genome? Retrotransposition rates (RR) for all classes of retrotransposons
combined or L1 elements only have been previously estimated to
be on the order of one new insertion every 2–30births, based on the
frequency of disease-causing de novo retrotransposon events
compared to nucleotide mutations and cell-culture based retrotransposition assays (Kazazian, 1999; Li et al., 2001; Brouha et al.,
2003). By contrast, Alu RR estimated using evolutionary
approaches are on the order of one insertion every 100–125births
(Deininger and Batzer, 1993; Deininger and Batzer, 1995). Because
these Alu RR were obtained prior to the sequencing of the human
and chimpanzee genomes (which allow higher resolution estimates
of the number of human and chimpanzee lineage-specific Alu
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elements), we have re-evaluated the evolutionary-based Alu RR
estimates. In addition, we have used a second independent
approach to estimate the Alu RR, based on the frequency of
disease-causing de novo Alu insertions as compared to nucleotide
mutations (Kazazian, 1999). Strikingly, we found that, although the
two methods use different assumptions, they both produce similar
Alu RR estimates of one insertion every ∼20births.
2. Materials and methods
2.1. Evolutionary-based method
First, using an evolutionary framework, we estimated the
average human Alu RR over the past ∼6 million years. Assuming a neutral model of evolution, we inferred the RR that
explains the copy number of fixed human-specific Alu elements
if genetic drift is the sole driving evolutionary force. Under this
model, the frequency of each element in the population fluctuates randomly and this force drives the loss or fixation of the
element. Population genetics theory predicts that the probability
of fixation of any element under neutral evolution is 1 / 2Ne,
where Ne is the human effective population size (Graur and Li,
2000). Thus, the expected total number of Alu insertions (i.e.
encompassing insertions that ultimately became fixed or lost, as
well as currently polymorphic elements) that must have
occurred in humans to produce n fixed human-specific elements
at the time of observation (present-day) is n2Ne. For a human–
chimpanzee divergence time t and a generation time g, the RR
expected under a neutral model of evolution is n2Ne / (t / g) / Ne
new insertion events per birth. As this expression results in a
fractional insert value, it can be more intuitively expressed as
one new insertion event every (2ng / t)− 1 births. We emphasize
here that, because Ne is factored out of the equation, the number
or severity of population bottlenecks having occurred in recent
human evolution is irrelevant to this calculation.
2.2. Mutation-based method
The second approach we used estimates the current-day
human Alu RR by comparing the frequency of de novo Alu
insertions involved in genetic disease in humans to that of de
novo nucleotide mutations causing disease in the same set of
genes (Kazazian, 1999), as reported in the Human Gene Mutation Database (HGMD) (Stenson et al., 2003; Chen et al., 2005).
The HGMD has not been specifically designed to calculate RR.
Therefore, the accuracy of this approach is limited by the data
present in the database and the results can potentially be influenced by several sources of bias, such as unreported mutations at non-disease-causing sites and parallel mutations.
Using estimates of the extent of bias that these two major sources
(see descriptions below) may exert on the HGMD data, we
corrected the observed Alu RR to obtain more reliable estimates.
2.2.1. Unreported mutations at non-disease-causing sites
While most (if not all) Alu insertions in the protein encoding
portion of a gene are likely to have detectable phenotypic effects
(e.g., by truncating the protein encoded by the gene), many
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nucleotide substitutions do not modify the encoded amino acid
(i.e., synonymous substitutions) or result in a conservative
amino acid substitution with no detectable phenotypic effect.
Such single base substitutions are not listed in the HGMD,
which therefore leads to an overestimate of the RR because it
decreases the frequency of nucleotide mutations relative to Alu
insertion events. To quantify this effect, we estimated the proportion of synonymous nucleotide substitutions and nonsynonymous nucleotide substitutions resulting in conservative
amino acid changes out of all possible nucleotide substitutions.
The proportions of synonymous and non-synonymous nucleotide substitutions were estimated according to the codon base
positions of the human genetic code (Strachan and Read, 2004).
Conservative and non-conservative amino acid substitutions
were defined according to the BLOSUM62 matrix (Henikoff
and Henikoff, 1992); changes with a positive or neutral sign in
the matrix were considered conservative changes while those
with negative signs were considered non-conservative (Cargill
et al., 1999).
2.2.2. Parallel mutations
Alu elements are essentially homoplasy-free characters,
particularly at the scale of human evolution (Ray et al., 2005;
Salem et al., 2005; Xing et al., 2005), indicating that Alu parallel
insertions are not a concern for estimating RR. By contrast,
nucleotides are more prone to parallel or homoplasic mutations
and nucleotide mutations at any site are counted only once in the
HGMD (Stenson et al., 2003), even though multiple independent nucleotide mutations might have occurred at the same site
(Li et al., 2001; Stenson et al., 2003). This source of bias leads
to an overestimate of the RR. To quantify this effect, we
estimated the proportion of parallel nucleotide mutations from
∼5.5 kb of pseudogene sequence determined in 100 human
chromosomes (Martinez-Arias et al., 2001). As the neutral
substitution rate equals the spontaneous mutation rate (Graur
and Li, 2000; Nachman and Crowell, 2000), the proportion of
parallel substitutions observed in neutrally evolving pseudogene sequences equals the proportion of spontaneous parallel
mutations in the HGMD.
3. Results
3.1. Evolutionary-based method
The comparison of the human and chimpanzee genomes
yielded an estimate of the total number of human-specific Alu
elements of 7082 (Chimpanzee Sequencing and Analysis
Consortium, 2005). This figure includes both polymorphic and
fixed elements. Since the vast majority of human-specific Alu
elements belong to the Ya and Yb lineages in which ∼80% of the
elements are fixed in the population (Carter et al., 2004; Otieno et
al., 2004), we deduce that there are ∼5700 fixed human-specific
Alu elements. Using this number of fixed human-specific Alu
copies n, a human–chimpanzee divergence time t of 6million
years (Goodman et al., 1998), and a generation time g of 20–
30years, we estimate that the average Alu RR has been one
insertion every 18–26individuals over the past ∼6million years.
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Table 1
Human Alu retrotransposition rate (births/insertion) based on disease-causing
mutations
Number of de novo mutations

Alu
elements

Nucleotide
mutations

Reported in the HGMD as of November 2004
Missed due to unreported mutations at nondisease-causing sites
Missed due to parallel mutations
Corrected estimates
Alu retrotransposition rate

26
–

29,505
21,495 a

–
26
14–16 c

0–6000 b
51,000–57,000

a

Total non-synonymous nucleotide substitutions (i.e., encompassing nonconservative and conservative amino acid changes)= 38,930 (29,505/ 75.8%). The
value of 75.8% is derived from the BLOSSUM62 amino acid substitution matrix
(Henikoff and Henikoff, 1992), in which 144 / 190 (75.8%) of all possible amino
acid substitutions are predicted to be non-conservative. Total nucleotide mutations
(i.e., encompassing non-synonymous and synonymous substitutions) =
51,000 (38,930/ 76.3%). The value of 76.3% is derived as follows: ∼96%,
100% and ∼33% of all substitutions occurring at first, second and third codon
positions, respectively, are non-synonymous (Strachan and Read, 2004), and codon
usage barely affects these percentages (e.g., accounting for codon usage shifts the
proportion of non-synonymous substitutions at first codon position from 95.6% to
96.1%). Thus, assuming that each codon position has the same probability of being
hit by a spontaneous mutation, 76.3% (96 + 100+ 33 out of 300 spontaneous
mutations) are expected to be non-synonymous.
b
= (29,505 + 21,495) × 11.8%. The value of 11.8% is derived from the
analysis of ∼500 kb of human pseudogene sequence that contained
17 polymorphic sites involving nucleotide substitutions where parallel
mutations were inferred to have occurred at no more than two sites (MartinezArias et al., 2001). Thus, the proportion of polymorphic sites having
experienced parallel mutations ranges from 0% (0 / 17) to 11.8% (2 / 17).
c
51,000 / 26 / 140 and 57,000 / 26 / 140 (where 140 is the number of
spontaneous nucleotide mutations per diploid genome per generation; see
Section 3.2).

3.2. Mutation-based method
As of November 2004, the HGMD contained 29,505
independent de novo nucleotide mutations as well as 26 de
novo Alu insertions located in 1690 genes (Stenson et al., 2003;
Chen et al., 2005). Correcting for unreported nucleotide mutations in the HGMD occurring at sites where no disease-causing
mutation is known and for parallel nucleotide mutations results
in a total of 51,000–57,000 actual nucleotide mutations (see
Table 1 for details). Thus, the frequency of Alu insertions
relative to nucleotide mutations is one in ∼2000–2200. Assuming a spontaneous nucleotide mutation rate of 2.3 × 10− 8 per
site per generation (Nachman and Crowell, 2000) and 6.2 × 109
nucleotides per diploid genome, there are on average ∼140
spontaneous nucleotide mutations per diploid genome per
generation. This translates into a current-day Alu RR of one new
insertion every ∼15 individuals (Table 1).
4. Discussion
The two methods we used consistently yielded Alu RR on the
order of one insertion every ∼20 births. The fact that these
methods are independent in that they are based on different
assumptions and use different datasets adds to the credibility of
our Alu RR estimate, even though each method has its own
inherent uncertainties. For example, for the method using

disease-causing Alu elements and nucleotide mutations, we
used a database that was not originally designed for the purpose
of calculating RR (Stenson et al., 2003). Therefore, although the
HGMD is the best suited database currently available for the
type of analysis we performed, it has inherent biases that need to
be corrected. We speculate that if more accurate Alu RR based
on the disease-causing elements method can be estimated in the
future, it may become possible to address questions related to
selective forces acting on Alu elements, by comparing the
improved Alu RR estimate to that expected under neutral
evolution. Also, it is noteworthy that the evolutionary RR is an
average RR over the past few million years and it is possible that
the Alu RR has varied during this time period. The fact that
different recent Alu subfamilies have different estimated ages
and copy numbers (Xing et al., 2004; Hedges et al., 2005) is
consistent with the idea of temporal Alu RR variation, although
its magnitude is difficult to estimate. The observation that the
disease-based Alu RR (which better reflects the present-day Alu
RR) is slightly faster than the evolutionary Alu RR may suggest
that, within the limits of accuracy of the methods used, Alu
elements are currently in a phase of slightly higher retrotranspositional activity than average.
The Alu RR we estimated here is about five times faster than
the Alu RR previously estimated by evolutionary methods (Deininger and Batzer, 1993, 1995). This is not completely unexpected given that the recent availability of sequence data from the
human and chimpanzee genome projects has allowed refined
estimates of the number of human-specific Alu elements (Lander
et al., 2001; Chimpanzee Sequencing and Analysis Consortium,
2005). Our results confirm that Alu elements continue to vigorously proliferate in the human lineage (Hedges et al., 2004; Chen
et al., 2005; Chimpanzee Sequencing and Analysis Consortium,
2005), although the current Alu RR is much lower than it was
∼40million years ago when the majority of Alu elements were
generated (Batzer and Deininger, 2002).
Our results also suggest that Alu and L1 RR are fairly similar,
both being on the order of one insertion every ∼20 births (this
study; Kazazian, 1999; Li et al., 2001; Brouha et al., 2003). This
suggests that Alu elements might have a similar retrotransposition efficiency compared to L1 elements vis-à-vis the molecular
retrotransposition machinery. This result is somewhat unexpected, given that L1 proteins are more efficient at retrotransposing
the mRNA that encodes them than they are for any other RNA,
including Alu RNA (Dewannieux et al., 2003). Nevertheless, Alu
elements can be retrotransposed by L1 elements in which only
ORF2 is functional; by contrast, L1 retrotransposition requires
both ORF1 and ORF2 to be functional (Ostertag and Kazazian,
2001; Dewannieux et al., 2003).
In conclusion, previous estimates of one new Alu insertion
every ∼100–125 births were developed prior to the sequencing
of the human and chimpanzee genomes. Here, we have used
two independent methods (based on the new genomic data and
on disease-causing de novo Alu insertions) to provide refined
estimates for the RR of Alu elements in humans. Both methods
consistently yielded RR on the order of one new Alu insertion
every ∼20births, despite the fact that the evolutionary-based
method represents an average RR over ∼6 million years while
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the mutation method represents current day RR. These results
suggest that Alu elements retrotranspose in humans at a rate
about five times faster than previously thought, and they testify
to the high potential of Alu elements as mutagenic factors in the
human genome.
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